Addressing threats to health care's core values, especially those stemming from concentration and abuse of power - and now larger threats to the democracy needed to advance health and welfare. Advocating for accountability, integrity, transparency, honesty and ethics in leadership and governance of health care.
Pages
▼
Tuesday, June 26, 2007
BLOGSCAN - Dodgy marketing of Pfizer Anti-Viral Drugs
On Question Authority with Dr Peter Rost there have been a series of posts, (the most recent one is here), about allegations that Pfizer Inc started marketing its new antiviral drug for HIV, maraviroc, before the drug received US Food and Drug Administration (FDA) approval. Now Pharmalot has a post picking up the maraviroc story, and looking at related allegations that Pfizer improperly marketed its old antiviral drug Viracept (nelfinivir).
No comments:
Post a Comment